Chargement en cours...
The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats
BACKGROUND: Given the problems associated with the escalation in methamphetamine (METH) use, the identification of more effective treatment strategies is essential. Group II metabotropic glutamate receptors (mGluRs) have been suggested to be a novel therapeutic target for psychostimulant addiction....
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3804156/ https://ncbi.nlm.nih.gov/pubmed/23953655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2013.07.024 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|